Study Indicates Adolescent Smokers Are More Susceptible To Long-Term DNA Damage From Smoking Than Adults Smokers

April 06, 1999

Adolescent smokers appear to be more susceptible to long-term DNA damage associated with lung cancer than people who start smoking as adults, according to a study led by a UC San Francisco researcher that examined DNA damage in former smokers who have lung cancer.

The study, published in the April 6 issue of Journal of the National Cancer Institute, indicates that ex-smokers with lung cancer who began smoking in adolescence had higher levels of chemically altered DNA in their lungs and blood than ex-smokers who started smoking later in life. The study accounted for numerous variables, including the number of years ex-smokers smoked and the amount they smoked.

"Our finding suggests that young smokers incur more severe or persistent DNA damage than adult smokers do," said the lead author of the study," John K. Wiencke, PhD, associate professor of epidemiology at UCSF.

"Smoking during adolescence may produce physiologic changes that lead to persistent increased DNA damage, or young smokers may be markedly susceptible to DNA damage formation and have higher burdens of damage after they quit smoking than those who started smoking later in life," said Wiencke.

All smokers develop some level of DNA damage, which is a known risk factor for lung cancer, and all people who quit experience some level of DNA repair. The current finding suggests that less repair - or less successful repair - occurs in people who smoked as adolescents.

The finding was drawn from a broader investigation that sought to parse out correlations between the various possible factors contributing to lung cancer - such as years and intensity of smoking--and DNA damage in the lungs.

"The ability to identify those current and former smokers with the highest risk of developing cancer has substantial preventive implications," said Wiencke. The damaged, or chemically altered segments of DNA, known as DNA adducts, are physical complexes in genes that are known to result from exposure to carcinogens, and they are believed to be one of the first steps in the carcinogenic pathway that ultimately leads to tumor formation. In tobacco smoke, carcinogens known as polynuclear aromatic hydrocarbons (PAHs) bind to such genes as p53 and are strongly suspected of initiating lung tumor formation.

The researchers conducted their study by examining DNA adduct levels in nontumorous lung tissue samples from 143 lung cancer patients and blood samples from fifty-seven these patients. Fifty-seven of the patients were current smokers, 79 were ex-smokers and seven had never smoked.

In the lung tissue of people who had never smoked, DNA adduct levels were low; in current smokers, they were eight times higher; and, in ex-smokers, they were 3.5 times higher.

In current smokers, a high number of cigarettes smoked per day was the variable most closely related to high addict levels.

In former smokers, however, the age at which a person began smoking was the strongest indicator of DNA adduct levels. Highest levels of DNA damage were observed in individuals who began smoking between the ages of 9 and 12 years.

The researchers propose two possible explanations for why age might impact smoking-related DNA adduct levels. One possibility is that smoking at an early age, a time of rapid lung growth and development, induces long-lasting physiologic changes that impair the removal of damaged units in the DNA.

Another possibility is that very young smokers accumulate more damaged DNA, and that, even with repair, the damage remains many years after smoking cessation, in contrast to subjects who begin to smoke later. Neither of these mechanism has been examined in humans.

The authors also determined that levels of DNA adducts in circulating blood cells have a higher statistical correlation with levels in the lung tissue samples, indicating that measurements from blood cells may well act as a reliable indicator of DNA adduct levels in tissue.

Overall, the findings should fuel efforts to pinpoint how precisely DNA adduct levels correlate with the various factors suspected of contributing to individual susceptibility to lung cancer, including smoking history, genetics, diet and occupation and now, perhaps age at which smoking occurs.

"To our knowledge, no other study has considered the age at which smoking was initiated as a potential predictor of tobacco smoke-related DNA damage in former smokers," said Wiencke.

Co-authors of the study were Andrea Varkonyi, of the Laboratory for Molecular Epidemiology, Department of Epidemiology and Biostatistics, at UCSF; Sally W. Thurston and Karl T. Kelsey, Harvard School of Public Health; John C. Wain, Massachusetts General Hospital; Eugene J. Mark, Harvard Medical School; and David C. Christiani, Harvard School of Public Health, Massachusetts General Hospital and Harvard Medical School.

The study was funded by the National Institute of Environmental Health Sciences, the National Cancer Institute, the National Institutes of Health, and the Department of Health and Human Services.
-end-


University of California - San Francisco

Related Lung Cancer Articles from Brightsurf:

State-level lung cancer screening rates not aligned with lung cancer burden in the US
A new study reports that state-level lung cancer screening rates were not aligned with lung cancer burden.

The lung microbiome may affect lung cancer pathogenesis and prognosis
Enrichment of the lungs with oral commensal microbes was associated with advanced stage disease, worse prognosis, and tumor progression in patients with lung cancer, according to results from a study published in Cancer Discovery, a journal of the American Association for Cancer Research.

New analysis finds lung cancer screening reduces rates of lung cancer-specific death
Low-dose CT screening methods may prevent one death per 250 at-risk adults screened, according to a meta-analysis of eight randomized controlled clinical trials of lung cancer screening.

'Social smokers' face disproportionate risk of death from lung disease and lung cancer
'Social smokers' are more than twice as likely to die of lung disease and more than eight times as likely to die of lung cancer than non-smokers, according to research presented at the European Respiratory Society International Congress.

Lung cancer therapy may improve outcomes of metastatic brain cancer
A medication commonly used to treat non-small cell lung cancer that has spread, or metastasized, may have benefits for patients with metastatic brain cancers, suggests a new review and analysis led by researchers at St.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Lung transplant patients face elevated lung cancer risk
In an American Journal of Transplantation study, lung cancer risk was increased after lung transplantation, especially in the native (non-transplanted) lung of single lung transplant recipients.

Proposed cancer treatment may boost lung cancer stem cells, study warns
Epigenetic therapies -- targeting enzymes that alter what genes are turned on or off in a cell -- are of growing interest in the cancer field as a way of making a cancer less aggressive or less malignant.

Are you at risk for lung cancer?
This question isn't only for people who've smoked a lot.

Read More: Lung Cancer News and Lung Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.